NCT01675609View on ClinicalTrials.gov

Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

57

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2012

Conditions

Ocular Redness

Interventions

DRUG

Placebo

1 drop in each eye daily for up to 35 days

DRUG

Brimonidine tartrate 0.025%

1 drop in each eye for up to 35 days

Trial Locations (1)

01810

Ora, Inc., Andover

Sponsors

Lead Sponsor

Eye Therapies, LLC

All Listed Sponsors

lead

Eye Therapies, LLC

INDUSTRY

NCT01675609 - Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects | Biotech Hunter | Biotech Hunter